Neurotrope Announces First Patient Dosed in Long-Term Clinical Trial of Bryostatin in Alzheimer’s …,

The new Phase 2 clinical study, which is expected to enroll approximately 100 patients, will evaluate Bryostatin-1 in the absence of Namenda® …, The new Phase 2 clinical study, which is expected to enroll approximately 100 patients, will evaluate Bryostatin-1 in the absence of Namenda® …, Read More